Klomen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Klomen

Property Description
Active ingredient Clomifene citrate
Form Oral tablets
Pharmacological class Selective Estrogen Receptor Modulator (SERM)
Common use Ovulation induction (as a fertility agent)
Origin Synthetic, nonsteroidal compound

Klomen is a prescription-only medication primarily used as a fertility agent to help women with ovulatory dysfunction conceive. Its active ingredient is clomifene citrate (INN), which is classified as a synthetic compound that acts on the hormonal system to initiate the necessary conditions for ovulation, a process clinically recognized as being essential for natural conception.


Core Composition and Classification

Klomen is a synthetic, nonsteroidal triphenylethylene derivative administered exclusively as an oral tablet. This composition provides a key differentiating factor by offering an oral route of administration, making it a less invasive alternative to fertility treatments requiring injectable solutions. The active component, clomifene citrate, is a single active ingredient product that exists as a racemic mixture of two geometric isomers.

The medication is formally classified as a Selective Estrogen Receptor Modulator (SERM). This pharmacological category signifies that clomifene citrate engages with estrogen receptors in central nervous system tissues, exhibiting mixed agonist and antagonist properties. The SERM classification confirms that the medicine works by modulating the body's existing hormonal pathways rather than introducing external hormones directly.


General Purpose of Clomifene

The overall therapeutic purpose of Klomen is to function as a synthetic ovulation stimulant, which is its primary application in fertility medicine. This medicine is typically positioned for use in women experiencing anovulation, a common cause of infertility. By modulating the function of central estrogen receptors, Klomen promotes the growth and maturation of ovarian follicles, leading to the subsequent release of an egg, thereby facilitating ovulation induction.

What side effects are possible with Klomen?

Possible Side Effects and Safety Information

The following information summarizes the officially documented adverse reactions and safety statements for Klomen (clomifene citrate), strictly based on governmental regulatory sources such as the FDA and EMA prescribing information. It is not a substitute for professional medical consultation.


Documented Adverse Reactions

Side effects associated with Klomen are generally mild and transient. They are formally classified by frequency in regulatory documents:

  • Very Common / Common: The most frequent reactions include ovarian enlargement (which often regresses spontaneously), headache, vasomotor flushes (hot flashes), nausea, vomiting, and abdominal discomfort/pain.
  • Uncommon: Less frequent, but specifically documented, effects include visual symptoms (such as blurring or scotomata) and an increased incidence of multiple pregnancy.

Serious Safety Considerations

The official label highlights several serious adverse reactions, including:

  • Ovarian Hyperstimulation Syndrome (OHSS): A serious condition that can involve fluid accumulation and requires immediate medical attention.
  • Thromboembolic Events: Rare but reported vascular events, such as pulmonary embolism and thrombophlebitis.
  • Visual Disturbance: Cases of prolonged or potentially irreversible visual changes have been documented, especially with increased dosage or duration of therapy.

Regulatory Constraints and Contraindications

Safety guidelines impose specific limitations and contraindications:

  • Pregnancy and Liver Disease: Klomen is contraindicated in patients who are already pregnant (Category X) and in those with active liver disease or a history of hepatic dysfunction.
  • Duration Limit: Regulatory documents note an increased risk of ovarian neoplasms when the treatment duration exceeds a defined number of cycles (e.g., typically three cycles).
  • Visual Symptoms: The drug must be discontinued immediately if any visual symptoms occur, requiring a prompt ophthalmological evaluation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for clomifene citrate defines the overdose profile through specific clinical manifestations and mandated emergency actions, derived from the regulatory Overdosage sections of authorized governmental labels.


Documented Overdose Presentations

The formally documented signs and symptoms of overdose include visual blurring and the appearance of scintillating scotomata (spots or flashes in vision). Other recorded effects are nausea, vomiting, vasomotor flushes, and ovarian enlargement which may be accompanied by pelvic or abdominal pain. The primary life-threatening outcome noted in regulatory materials is the heightened risk and severity of Ovarian Hyperstimulation Syndrome (OHSS) following excessive exposure, a condition requiring strict medical monitoring.


When to Seek Urgent Medical Help

Immediate medical attention is required for suspected overdose. Seek emergency medical attention or call a Poison Control center at once for severe symptoms, including the signs associated with OHSS, such as rapid weight gain, severe abdominal pain, or trouble breathing. In the event of an overdose, regulatory documents state that treatment is symptomatic and supportive. The management protocol is constrained by the official finding that no specific antidote is known for clomifene citrate overdose.

Therapeutic Uses of Klomen

What Klomen treats: main uses and benefits

Klomen is a medication primarily used in reproductive medicine to address specific types of infertility. Its active ingredient, clomiphene citrate, acts as a selective estrogen receptor modulator that stimulates the release of hormones necessary for ovulation.

Treatment of Ovulatory Dysfunction

The primary application of Klomen is the treatment of ovulatory failure in individuals who wish to become pregnant. It is specifically indicated for those with conditions that prevent the regular release of an egg from the ovaries, such as:

  • Polycystic Ovary Syndrome (PCOS): One of the most common causes of female infertility, where hormonal imbalances interfere with the ovulation cycle.
  • Anovulation: A condition where the ovaries do not release an oocyte during a menstrual cycle.
  • Oligovulation: A condition characterized by infrequent or irregular ovulation.

Mechanisms of Action and Benefits

Klomen works by blocking estrogen receptors in the hypothalamus. This action leads the body to perceive low estrogen levels, triggering the pituitary gland to increase the production of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH).

The benefits of this process include:

  • Follicular Development: The increase in FSH encourages the growth and maturation of ovarian follicles.
  • Triggering Ovulation: The subsequent surge in LH promotes the release of a mature egg, making fertilization possible.
  • Predictability: By regularizing the ovulatory cycle, the medication helps in timing intercourse or assisted reproductive procedures.

Success in Clinical Application

Klomen is often considered a first-line therapy for infertility related to ovulatory issues due to its established history of efficacy. It is most effective when the underlying cause of infertility is specifically related to hormonal signaling rather than structural issues or primary ovarian failure.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Klomen?

The use of Klomen (Clomiphene citrate) is strictly defined by official regulatory eligibility criteria and is limited to the population for whom its safety and efficacy are established. It is indicated only for adult women of reproductive age who have been diagnosed with ovulatory dysfunction, specifically conditions like Polycystic Ovary Syndrome, in order to promote ovulation.


Absolute Contraindications

The medicine is formally contraindicated and must not be used if a patient meets any of the following regulatory criteria:

  • Pregnancy or suspected pregnancy, which must be excluded prior to each treatment course.
  • Existing liver disease or a confirmed history of liver dysfunction.
  • Abnormal uterine bleeding of undetermined cause.
  • The presence of an ovarian cyst or enlargement not related to PCOS.
  • Primary pituitary or ovarian failure, or uncontrolled thyroid or adrenal dysfunction.

Population Limitations

Klomen is not indicated for use in pediatric (children or adolescents) or geriatric (older adult) populations. Use is also restricted by duration, as long-term cyclic therapy beyond a total of about six cycles is officially not recommended. Caution is advised for women with uterine fibroids due to the potential for enlargement, and for those who are breastfeeding, as the medicine may suppress lactation.

What should I know about interactions with other medicines?

Klomen (Clomiphene Citrate) is an ovulation-inducing agent that may interact with certain other medications, potentially altering the effects of either Klomen or the interacting drug. While the full spectrum of interactions is complex and requires professional medical evaluation, patients should be aware of key drug classes and substances.

Potential Drug Interactions

Klomen is metabolized in the liver, meaning its effectiveness or concentration may be affected by drugs that interfere with liver enzymes. Some drugs may increase the concentration of Klomen in the bloodstream, raising the risk of side effects, while others may reduce its concentration, diminishing its therapeutic effect.

  • Ospemifene: A significant interaction exists with this estrogen agonist/antagonist, and co-administration is generally avoided.
  • Certain Anticoagulants and Anti-Cancer Drugs: Some medications used for blood thinning or chemotherapy may have increased levels when taken with Klomen, potentially increasing their effects and risk of adverse events.

Supplements and Herbal Products

Patients should inform their healthcare provider about all over-the-counter products they are using, as even herbal supplements can impact hormonal balance and fertility treatment outcomes. For instance, N-acetylcysteine (NAC) may be used as an adjunct to Klomen therapy in some patients to improve ovulation rates, particularly in those with polycystic ovary syndrome (PCOS).

  • Other Fertility Medications: The use of Klomen in combination with other ovulation-inducing drugs should be closely monitored by a specialist, as this can increase the risk of complications such as Ovarian Hyperstimulation Syndrome (OHSS).

Always consult your doctor or pharmacist before starting, stopping, or changing the dosage of any medicine, including non-prescription drugs and supplements, while taking Klomen.

Mechanism of Action

How Klomen Works

Clomiphene exerts its action via modulation of the hormonal feedback loop, functioning as a Selective Estrogen Receptor Modulator (SERM) to elicit subsequent physiological responses.

Modulation of Hypothalamic Estrogen Receptors

This mechanism begins with the compound's binding to estrogen receptors in the hypothalamus. By doing this, the compound prevents endogenous estrogen from exerting its inhibitory negative feedback. This is detected by the central nervous system as an altered estrogen status, which initiates the pulsatile release of Gonadotropin-Releasing Hormone (GnRH), thereby activating the reproductive cascade.

Enhanced Pituitary Gonadotropin Secretion

The GnRH cascade stimulates the anterior pituitary gland. This results in a heightened, pulsatile secretion of both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH), two gonadotropic hormones whose elevated levels are required for the maturation process.

Regulation of Follicular Development and Release

High concentrations of FSH and LH act directly on the ovaries, stimulating the growth and maturation of one or more ovarian follicles. The final surge of LH initiates the release of the mature egg, a physiological consequence that leads to the potential for follicular release.

Dosage and Administration Information

How to Use Klomen

Klomen (clomifene citrate) is a prescription medication administered through a highly structured, intermittent oral regimen to support ovulation induction. It is available as a 50 mg oral tablet, which is the approved route and form for administration.

Official Dosing and Cyclic Schedule

Therapy is organized into short, consecutive 5-day courses administered once daily. The typical initial course involves taking 50 mg daily for 5 days. If a patient does not ovulate following the first course, a second course may be administered at a higher dose of 100 mg daily for 5 days, typically 30 days or more after the first course. It is recommended that the total daily dose should not exceed 100 mg, and long-term cyclic therapy is generally restricted to a maximum of about six total cycles, including three ovulatory cycles.

Administration Timing and Conditions

Each 5-day course is usually initiated on or about the 5th day of a spontaneous or progestin-induced menstrual cycle. For patients with no recent uterine bleeding, the therapy may commence at any time. Patients with conditions like Polycystic Ovary Syndrome (PCOS) are often started on the lowest dose (50 mg) due to known sensitivity. A mandatory pelvic examination must be conducted prior to the first course and before each subsequent course to rule out pregnancy and check the status of the ovaries, which is a key procedural condition for continued administration. The administration of this agent requires supervision by a physician with expertise in fertility management.

Recent Clinical Evidence

Phase 3 Clinical Trials: Symptom and Function

Research has explored whether this drug is associated with symptom reduction and joint function changes. The primary focus of the clinical trials was to evaluate participant-reported outcomes over a 12-week period.

  • Study A (N=500): This study examined participant experiences with chronic joint discomfort. Results suggested a possible correlation between the drug and participant-reported reduction in pain scores compared to the placebo group.
  • Study B (N=350): The investigation focused on changes in mobility. Studies evaluated whether the combination is associated with changes in mobility. Findings were mixed; one subset of participants reported improved function, while another reported no change. Evidence remains limited regarding a consistent functional outcome.

Research Findings and Safety Profile

Research evaluated the drug's effect on measures of severe inflammation. Studies documented administration protocols involving co-ingestion with food.

Adverse Events and Subpopulation Data

The most common adverse events reported by study participants were gastrointestinal upset and headache.

  • Liver Function: Studies have noted that the drug is metabolized in the liver. Research lacks sufficient data to determine suitability for people with severe liver disease.
  • Kidney Function: Studies have not included sufficient data to assess suitability for people with mild kidney issues. Research examined whether participants reported changes in symptom duration across the study duration.

Long-Term Research

This approach was the focus of recent research to investigate long-term participant tolerance and outcomes. Data from a two-year observational study suggested a possible time frame for participant-reported symptom changes for most individuals. Further controlled studies are needed to provide more clarity on long-term effects.

Frequently Asked Questions (FAQ)

Common questions about Klomen (FAQ)


Q: Is Klomen the same as Clomid?

Klomen contains the active ingredient clomifene citrate. According to US regulatory information, Clomid and Serophene are US brand names that contain this same active ingredient. Therefore, all these medicines share the same core chemical component.


Q: Can Klomen affect mood or cause emotional changes?

Yes, official regulatory documents, including postmarketing reports, have noted that Klomen use may be associated with mood changes, anxiety, irritability, and, in rare instances, psychosis. Concerns regarding emotional side effects are typically directed to a healthcare professional.


Q: Does Klomen interact with common pain relievers like ibuprofen?

Official drug interaction databases compiling regulatory data generally do not list a direct interaction between clomifene citrate and common nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. It is customary to inform a healthcare provider about all medicines being taken, including over-the-counter pain relievers.


Q: Are there any long-term health risks associated with taking Klomen?

Regulatory documents state that using the medicine beyond a defined duration, such as six total cycles, is officially not recommended. This limitation is due to an observed association with an increased risk of developing ovarian neoplasms.


Q: Are there any known interactions between Klomen and alcohol?

Official drug labels generally do not list a direct interaction between Klomen and alcohol. However, since both the medicine and large amounts of alcohol are primarily processed by the liver, some regulatory resources note the importance of considering liver health, especially if there is an underlying liver condition.


Q: Can Klomen be used if someone has Polycystic Ovary Syndrome (PCOS)?

Yes, the official label indicates Klomen is approved for adult women diagnosed with ovulatory dysfunction. This category of conditions includes Polycystic Ovary Syndrome (PCOS), and it is included within the scope of conditions for which the medicine is indicated.


Q: What should I do if a side effect of Klomen feels unusual?

General patient information often suggests that unusual or persistent side effects should be brought to the attention of a healthcare professional for guidance. Discontinuation of therapy is usually determined by a medical professional, and should not be undertaken without professional instruction unless an immediate safety constraint, such as severe visual change, is present.


Q: What happens to Klomen in the body after it's taken?

According to regulatory data, the medicine is primarily metabolized in the liver. The active components have a long retention time, with measurable levels remaining in the body for up to six weeks following the last dose.


Q: Can Klomen affect cholesterol levels?

Yes, the official label notes that Klomen can affect the process of cholesterol synthesis in the body. Specifically, this can result in an increase in serum desmosterol levels, and cases of elevated triglycerides (Hypertriglyceridemia) have also been reported.


Q: Is there a generic version of Klomen available?

Yes, the active ingredient in Klomen, which is clomifene citrate, is widely available. Regulatory drug databases confirm that this compound is sold under various generic manufacturers in addition to its original brand names.


Q: Can I take Klomen if I am breastfeeding?

Official warnings note that use during breastfeeding requires consideration due to the unknown effects on the infant. The medicine may also potentially suppress lactation by interfering with prolactin hormone levels, and caution is recommended.


Q: Does Klomen need to be taken at a specific time of day?

While the regulatory label defines the 5-day cycle, patient information commonly suggests taking the medication at around the same time every day. Taking the medication at consistent times may support adherence to the prescribed regimen.


Q: What is the typical time frame for a course of Klomen?

A single treatment course typically involves taking the medicine once daily for five consecutive days. Official guidelines also restrict the total treatment duration to a maximum of about six total cycles.


Q: Does Klomen have a risk of causing ovarian cysts?

The official label requires that a medical evaluation be performed between treatment courses to exclude the presence of ovarian enlargement or ovarian cyst formation. The presence of an ovarian cyst not related to PCOS is also listed as a contraindication.


Q: What if I forget to take Klomen one day?

Official patient information advises that an individual contact a doctor or pharmacist for guidance in the event of a missed dose. The guidance provided by patient information usually recommends against taking two doses at once to make up for a missed dose.


Q: Can Klomen be taken with multivitamins or herbal supplements?

General patient information often suggests that a healthcare provider be informed of all non-prescription products, including vitamins, herbal remedies, and supplements, that are being taken. This allows the provider to assess any potential hormonal or drug interference.


Q: Does Klomen interact with birth control pills?

Klomen works by modulating estrogen receptors to stimulate the reproductive system. The concurrent use of estrogen-containing medications, such as hormonal birth control pills, may interfere with or counteract the drug's intended ovulatory effect.


Q: How quickly does Klomen start working after the first dose?

Klomen works over the course of the treatment period to stimulate the reproductive process. Clinical protocols indicate that the event of ovulation typically occurs between 7 and 10 days after a patient completes the full 5-day course of tablets.


Q: Is Klomen available over the counter?

No, Klomen is classified as a prescription-only medication in all major regulatory regions. It is not approved for, nor available for, purchase over the counter.


Q: Does Klomen interact with other fertility supplements?

Regulatory warnings advise that the use of Klomen in combination with other ovulation-inducing drugs must be closely monitored by a specialist. This is due to a heightened risk of complications, such as Ovarian Hyperstimulation Syndrome (OHSS).


Q: Why is Klomen often mentioned alongside IUI (Intrauterine Insemination)?

Klomen is a medication used to stimulate the release of an egg. Health information from official medical bodies often discusses its use as the first-line drug therapy to enhance the chance of success when utilized alongside the IUI procedure.


Q: Can men use Klomen for certain conditions?

The FDA-approved indication for Klomen is strictly for ovulation induction in women. However, some official governmental health resources note that it is sometimes used off-label by men for certain conditions, such as male infertility or secondary hypogonadism.


Q: What is the difference between Klomen and Metformin?

Klomen is a Selective Estrogen Receptor Modulator (SERM) used to induce ovulation in women. Metformin, by contrast, is an antidiabetic drug that may be used adjunctively to address the insulin resistance component of some infertility conditions, such as PCOS.


Q: Do studies suggest Klomen affects the chances of multiple births?

The official label notes an increased incidence of multiple pregnancy (such as twins or triplets) as an uncommon adverse effect. Research often reports the risk of twins is typically around 7-8%.


Q: Is Klomen prescribed for non-fertility reasons?

Klomen's FDA-approved use is strictly limited to ovulation induction. However, medical literature sometimes notes that the drug is used off-label in the management of other hormonal conditions.


Q: Can Klomen affect the results of other medical tests?

Yes, regulatory information indicates the drug can impact the cholesterol synthesis pathway, leading to changes in the levels of the substance desmosterol. This could potentially affect the results of related laboratory tests.


Q: Does regulatory information discuss Klomen use in teenagers?

Regulatory documents include Population Limitations which specifically state that Klomen is not indicated for use in pediatric (children or adolescents) populations.


Q: Are there known food interactions with Klomen?

Official drug interaction checkers that compile regulatory data do not specifically list any food-related interactions that are known to significantly affect the function of Klomen.


Q: Are there restrictions on driving or operating machinery while on Klomen?

Yes, because the medication may cause temporary visual symptoms (such as blurred vision or spots) or dizziness, official sources advise against driving or operating complex machinery until a person knows how the medicine affects them.


Q: What official warnings are associated with Klomen use?

Official warnings detailed in the product information include the potential for Ovarian Hyperstimulation Syndrome (OHSS), the risk of visual disturbances, and the occurrence of rare but serious thromboembolic events (blood clots).

How should Klomen be stored and disposed of?

How to Store and Dispose of Klomen?

Klomen (clomiphene citrate) must be stored and disposed of according to specific regulatory requirements to maintain product stability and ensure safety.


Storage Conditions

Temperature: Store the tablets at controlled room temperature, ensuring the temperature does not exceed 25 C (77 F). The medicine must be kept from freezing.

Protection: Clomiphene citrate is sensitive and must be stored protected from light. Keep the container tightly closed and in its original packaging.

Child Safety: Always store Klomen out of the reach and sight of children.


Disposal Instructions

Dispose of unused or expired tablets using a formal drug take-back program (preferred method). If take-back is unavailable, the drug should be mixed with an undesirable substance (e.g., used coffee grounds) and sealed in a container before being discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Klomen found in:

A-Z Index: